BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31671363)

  • 1. EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease.
    Levy A; Hendriks LEL; Berghmans T; Faivre-Finn C; GiajLevra M; GiajLevra N; Hasan B; Pochesci A; Girard N; Greillier L; Lantuéjoul S; Edwards J; O'Brien M; Reck M; Besse B; Novello S; Dingemans AC;
    Eur J Cancer; 2019 Nov; 122():109-114. PubMed ID: 31671363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus Report.
    Dingemans AC; Hendriks LEL; Berghmans T; Levy A; Hasan B; Faivre-Finn C; Giaj-Levra M; Giaj-Levra N; Girard N; Greillier L; Lantuéjoul S; Edwards J; O'Brien M; Reck M; Smit EF; Van Schil P; Postmus PE; Ramella S; Lievens Y; Gaga M; Peled N; Scagliotti GV; Senan S; Paz-Ares L; Guckenberger M; McDonald F; Ekman S; Cufer T; Gietema H; Infante M; Dziadziuszko R; Peters S; Porta RR; Vansteenkiste J; Dooms C; de Ruysscher D; Besse B; Novello S
    J Thorac Oncol; 2019 Dec; 14(12):2109-2119. PubMed ID: 31398540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Systematic Review.
    Giaj-Levra N; Giaj-Levra M; Durieux V; Novello S; Besse B; Hasan B; Hendriks LE; Levy A; Dingemans AC; Berghmans T;
    J Thorac Oncol; 2019 Dec; 14(12):2053-2061. PubMed ID: 31195177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinion.
    Hendriks LEL; Dooms C; Berghmans T; Novello S; Levy A; De Ruysscher D; Hasan B; Giaj Levra M; Giaj Levra N; Besse B; Vansteenkiste J; Dingemans AC;
    Eur J Cancer; 2019 Dec; 123():28-35. PubMed ID: 31655358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of a Highly Selective Surgical Approach to Oligometastatic Lung Cancer.
    Johnson KK; Rosen JE; Salazar MC; Boffa DJ
    Ann Thorac Surg; 2016 Oct; 102(4):1166-71. PubMed ID: 27344278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of clinically node-negative non-small cell lung cancer.
    Takahashi Y; Suzuki S; Matsutani N; Kawamura M
    Thorac Cancer; 2019 Mar; 10(3):413-420. PubMed ID: 30666803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS).
    Vilmann P; Clementsen PF; Colella S; Siemsen M; De Leyn P; Dumonceau JM; Herth FJ; Larghi A; Vazquez-Sequeiros E; Hassan C; Crombag L; Korevaar DA; Konge L; Annema JT
    Endoscopy; 2015 Jun; 47(6):545-59. PubMed ID: 26030890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of Practice in Mediastinal Lymph Node Staging for Non-Small Cell Lung Cancer in Canada.
    Turner SR; Seyednejad N; Nasir BS
    Ann Thorac Surg; 2018 Aug; 106(2):428-434. PubMed ID: 29596820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediastinal lymph nodes in patients with non-small cell lung cancer: preliminary experience with diffusion-weighted MR imaging.
    Hasegawa I; Boiselle PM; Kuwabara K; Sawafuji M; Sugiura H
    J Thorac Imaging; 2008 Aug; 23(3):157-61. PubMed ID: 18728541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.
    Griffioen GH; Toguri D; Dahele M; Warner A; de Haan PF; Rodrigues GB; Slotman BJ; Yaremko BP; Senan S; Palma DA
    Lung Cancer; 2013 Oct; 82(1):95-102. PubMed ID: 23973202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography.
    Al-Sarraf N; Aziz R; Gately K; Lucey J; Wilson L; McGovern E; Young V
    Eur J Cardiothorac Surg; 2008 Jan; 33(1):104-9. PubMed ID: 17977738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing the accuracy of 18F-FDG PET/CT interpretation of "mildly positive" mediastinal nodes in the staging of non-small cell lung cancer.
    Moloney F; Ryan D; McCarthy L; McCarthy J; Burke L; Henry MT; Kennedy MP; Hinchion J; McSweeney S; Maher MM; O'Regan K
    Eur J Radiol; 2014 May; 83(5):843-7. PubMed ID: 24581594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer.
    Herth FJ; Eberhardt R; Krasnik M; Ernst A
    Chest; 2008 Apr; 133(4):887-91. PubMed ID: 18263680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classifications of n2 non-small-cell lung cancer based on the number and rate of metastatic mediastinal lymph nodes.
    Ito M; Yamashita Y; Tsutani Y; Misumi K; Harada H; Miyata Y; Okada M
    Clin Lung Cancer; 2013 Nov; 14(6):651-7. PubMed ID: 24188630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
    Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Size of metastatic and nonmetastatic mediastinal lymph nodes in non-small cell lung cancer.
    Ikeda K; Nomori H; Mori T; Kobayashi H; Iwatani K; Yoshimoto K
    J Thorac Oncol; 2006 Nov; 1(9):949-52. PubMed ID: 17409977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution and prognosis of mediastinal lymph node metastases of nonsmall cell lung cancer.
    Guo D; Ni Y; Lv X; Zhang Z; Ye P
    J Cancer Res Ther; 2016 Oct; 12(Supplement):120-125. PubMed ID: 27721268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endobronchial ultrasonography for positron emission tomography and computed tomography-negative lymph node staging in non-small cell lung cancer.
    Shingyoji M; Nakajima T; Yoshino M; Yoshida Y; Ashinuma H; Itakura M; Tatsumi K; Iizasa T
    Ann Thorac Surg; 2014 Nov; 98(5):1762-7. PubMed ID: 25149044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of invasive mediastinal nodal staging versus positron emission tomography staging alone for early-stage non-small cell lung cancer treated with stereotactic body radiation therapy.
    Schonewolf CA; Verma V; Post CM; Berman AT; Frick MA; Vachani A; Lin C; Simone CB
    Lung Cancer; 2018 Mar; 117():53-59. PubMed ID: 28800837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.